SCHEMBL15624079

SCHEMBL15624079

N#CCCCCc1ccccc1N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.38
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HIF1A Q16665 3/20 0.36
EPAS1 Q99814 3/20 0.36
TBXAS1 P24557 2/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP3A4 P08684 2/20 0.35
CYP1A2 P05177 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALOX15 P16050 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MPO P05164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6751703 0.94 ATM (0.41) SIGMAR1ATML3MBTL1MEN1KMT2A
SCHEMBL31402003 0.86 MEN1 (0.43) SIGMAR1ATML3MBTL1MEN1KMT2A
SCHEMBL2062907 0.86 MEN1 (0.43) SIGMAR1ATML3MBTL1MEN1KMT2A
Hydrochloric Acid SCHEMBL27623677 0.84 MEN1 (0.42) SIGMAR1ATML3MBTL1MEN1KMT2A
SCHEMBL23159850 0.83 ALOX15 (0.47) SIGMAR1L3MBTL1MEN1KMT2ACYP3A4
SCHEMBL23159817 0.81 SIGMAR1 (0.46) SIGMAR1L3MBTL1MEN1KMT2ACYP3A4
SCHEMBL23159894 0.79 ALOX15 (0.47) SIGMAR1L3MBTL1MEN1KMT2ACYP3A4
SCHEMBL29720312 0.77 TAAR1 (0.48) ATML3MBTL1HIF1AEPAS1TBXAS1
SCHEMBL7006141 0.77 MPO (0.49) HIF1AKDM4EMPOSLC6A4
SCHEMBL30929931 0.77 SIGMAR1 (0.46) SIGMAR1L3MBTL1MEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2845592-A1 Benzoxazepin PI3K inhibitor compounds and methods of use F. Hoffmann-La Roche AG (CH) 2015-03-11 EP disclosed
EP-2711368-A1 Benzoxazepin PI3K inhibitor compounds and methods of use F. Hoffmann-La Roche AG (CH) 2014-03-26 EP disclosed